PL3413862T3 - Układ perfuzyjny - Google Patents

Układ perfuzyjny

Info

Publication number
PL3413862T3
PL3413862T3 PL17750002.2T PL17750002T PL3413862T3 PL 3413862 T3 PL3413862 T3 PL 3413862T3 PL 17750002 T PL17750002 T PL 17750002T PL 3413862 T3 PL3413862 T3 PL 3413862T3
Authority
PL
Poland
Prior art keywords
perfusion system
perfusion
Prior art date
Application number
PL17750002.2T
Other languages
English (en)
Inventor
Subhas Balaram Bhowmick
Prashant Kane
Samarth Kumar
Kirti Ganorkar
Original Assignee
Sun Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd. filed Critical Sun Pharmaceutical Industries Ltd.
Publication of PL3413862T3 publication Critical patent/PL3413862T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A61J1/12—Bag-type containers with means for holding samples of contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407—Infusion of two or more substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804—Flow controllers
    • A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6009—General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
PL17750002.2T 2016-02-09 2017-02-09 Układ perfuzyjny PL3413862T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201621004576 2016-02-09
PCT/IN2017/050055 WO2017138023A1 (en) 2016-02-09 2017-02-09 Perfusion system

Publications (1)

Publication Number Publication Date
PL3413862T3 true PL3413862T3 (pl) 2024-03-18

Family

ID=59563072

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17750002.2T PL3413862T3 (pl) 2016-02-09 2017-02-09 Układ perfuzyjny

Country Status (18)

Country Link
US (4) US11554207B2 (pl)
EP (2) EP3413862B8 (pl)
JP (2) JP7059190B2 (pl)
KR (1) KR102524115B1 (pl)
CN (1) CN109069342A (pl)
AU (1) AU2017218801B2 (pl)
BR (1) BR112018016287A2 (pl)
CA (1) CA3014168C (pl)
ES (1) ES2968415T3 (pl)
HK (1) HK1258361A1 (pl)
IL (1) IL261038B2 (pl)
MX (2) MX2018009670A (pl)
PH (1) PH12018501693A1 (pl)
PL (1) PL3413862T3 (pl)
RU (1) RU2728822C2 (pl)
SA (1) SA518392177B1 (pl)
WO (1) WO2017138023A1 (pl)
ZA (1) ZA201805610B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10098813B2 (en) 2014-09-03 2018-10-16 Sun Pharmaceutical Industries Limited Perfusion dosage form
PL3413862T3 (pl) 2016-02-09 2024-03-18 Sun Pharmaceutical Industries Ltd. Układ perfuzyjny
US20190105262A1 (en) * 2017-10-10 2019-04-11 Sun Pharmaceutical Industries Ltd. Intravenous infusion dosage form for pemetrexed
CN115148329B (zh) * 2022-08-12 2025-03-07 河南中栋医疗科技有限公司 热灌注药液浓度智能分析调节方法及系统

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447230A (en) 1981-08-05 1984-05-08 Quest Medical, Inc. Intravenous administration set assembly
JPS62221352A (ja) 1986-03-22 1987-09-29 株式会社新素材総合研究所 酸素による薬液の変質を防止する薬液入りプラスチック容器の製造方法
US5856081A (en) * 1991-07-08 1999-01-05 The American National Red Cross Computer controlled cryoprotectant perfusion apparatus
US5217860A (en) * 1991-07-08 1993-06-08 The American National Red Cross Method for preserving organs for transplantation by vitrification
DE4336336A1 (de) * 1992-11-23 1994-05-26 Lang Volker Kasetteninfusionssystem
US5786344A (en) 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
CN2211286Y (zh) * 1994-09-24 1995-11-01 陈利生 加温灌注抗癌机
JPH09168577A (ja) * 1995-12-20 1997-06-30 Sekisui Chem Co Ltd 癌治療用血液バッグ
US5896989A (en) 1998-02-20 1999-04-27 Bracco Research Usa Flexible medical container packaging
US6771697B1 (en) 1998-06-23 2004-08-03 Pctel, Inc. Spread spectrum handshake for digital subscriber line telecommunications systems
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
AU4564200A (en) 1999-04-29 2000-11-17 Aventis Pharma S.A. Method for treating cancer using camptothecin derivatives and 5-fluorouracil
US7243689B2 (en) 2000-02-11 2007-07-17 Medical Instill Technologies, Inc. Device with needle penetrable and laser resealable portion and related method
CA2408710C (en) 2000-05-15 2010-01-26 Celgene Corp. Compositions and methods for the treatment of colorectal cancer
US7352770B1 (en) 2000-08-04 2008-04-01 Intellon Corporation Media access control protocol with priority and contention-free intervals
US20050137971A1 (en) 2000-10-02 2005-06-23 Ibm Corporation Personally customizable credit card accounts
US6954505B2 (en) 2001-03-29 2005-10-11 Texas Instruments Incorporated Discrete multitone modulation with reduced peak-to-average ratio using unloaded subchannels
US20030039306A1 (en) 2001-04-06 2003-02-27 Redfern Arthur John Low peak-to-average ratio quiescent mode architecture and signal design method for DMT modems
US20030031240A1 (en) 2001-07-31 2003-02-13 Redfern Arthur J. Downstream only suspend-type Q-Mode
US6936413B1 (en) 2001-12-05 2005-08-30 Baxter International Inc. Methods and systems for preparing blood products
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
US7122210B2 (en) 2002-01-11 2006-10-17 Baxter International Inc. Bicarbonate-based solutions for dialysis therapies
EP2546152A3 (en) 2002-09-03 2014-03-26 Medical Instill Technologies, Inc. Sealed containers and methods of making and filling same
JP2004166847A (ja) 2002-11-18 2004-06-17 Otsuka Pharmaceut Factory Inc 点滴用調合装置、混合管、薬液容器、混合液容器、点滴用調合システムおよび点滴用の調合方法
JP4787455B2 (ja) 2002-12-12 2011-10-05 テルモ株式会社 ビタミンｂ１類含有水性製剤充填済み容器体を収容した包装体
DE60326393D1 (de) * 2002-12-23 2009-04-09 Medtronic Inc Systeme und methoden zum einstellen der dichte einer medizinischen lösung
MY141763A (en) 2003-09-18 2010-06-30 Novartis Ag Pharmaceutical products comprising bisphosphonates
US20080242691A1 (en) 2004-02-13 2008-10-02 Kabushiki Kaisha Yakult Honsha Aqueous Solution Preparation Containing Camptothecins
CN101128230B (zh) 2005-02-11 2010-09-29 麻省理工学院 表面注射装置
DE102005022428A1 (de) * 2005-05-14 2006-11-16 B. Braun Medizinelektronik Gmbh & Co. Kg Verfahren und Vorrichtung zur Steuerung einer Mehrzahl von Infusionspumpen
JP2010503696A (ja) 2006-09-13 2010-02-04 ヌベロ， インコーポレイテッド 癌を処置するための方法
US20110177161A1 (en) 2007-05-24 2011-07-21 Dr. Reddy's Laboratories Limited Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin
JP2009034462A (ja) * 2007-07-31 2009-02-19 Koosei Advance:Kk 膵臓治療用灌流システム
EP2259776A4 (en) 2008-02-29 2011-03-16 Eagle Pharmaceuticals Inc USEFUL TOPOTECAN SOLUTIONS
RU2496499C2 (ru) 2008-09-26 2013-10-27 Эститю Де Кансероложи Де Л'Вест Оптимизация индивидуальных доз 5-фторурацила при режиме folfiri
WO2010088973A1 (en) 2009-02-06 2010-08-12 Shl Group Ab Medicament delivery device with electronic dose sensor
KR20120111721A (ko) 2009-07-01 2012-10-10 프레제니우스 메디칼 케어 홀딩스 인코퍼레이티드 약물 전달 장치와 이에 관련된 시스템 및 방법
FR2951927A1 (fr) * 2009-11-05 2011-05-06 Centre Nat Rech Scient Dispositif de prelevement de liquide corporel et procede de mise en oeuvre.
FR2951951A1 (fr) * 2009-11-05 2011-05-06 Centre Nat Rech Scient Systeme de perfusion securise et procede de mise en oeuvre
SI2508170T1 (sl) 2009-12-03 2015-12-31 Jiangsu Hengrui Medicine Co., Ltd. Liposom z irinotekanom ali njegovim hidrokloridom in njun postopek priprave
JP2011250726A (ja) 2010-06-01 2011-12-15 Toyo Kohan Co Ltd イリノテカンの副作用の発生危険度を判定する方法及びそのためのキット
AR085215A1 (es) 2011-02-15 2013-09-18 Sanofi Aventis Deutschland Interfaz de dispensacion para uso con un dispositivo dispensador de farmacos que libera dos o mas agentes farmaceuticos
WO2012177798A2 (en) * 2011-06-20 2012-12-27 Renaudia Medical, Llc Distributed medication delivery system and method having autonomous delivery devices
WO2013171763A1 (en) 2012-04-27 2013-11-21 Sun Pharmaceutical Industries Ltd Ready to be infused gemcitabine solution
US9233776B2 (en) * 2012-06-07 2016-01-12 Bayer Healthcare Llc Molecular imaging vial transport container and fluid injection system interface
RU2015100517A (ru) 2012-06-13 2016-08-10 ДР. ПИ ИНСТИТЬЮТ ЭлЭлСи Устройство, имеющее протыкаемую перегородку, заполняющую иглу и протыкаемую крышку, и связанный с ним способ
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CN102824345B (zh) 2012-09-20 2014-03-26 江苏奥赛康药业股份有限公司 一种盐酸伊立替康组合物及其制备方法
CN102885765B (zh) 2012-10-25 2013-11-06 哈药集团生物工程有限公司 一种盐酸伊立替康注射液及其制备方法
CN103989624B (zh) 2013-02-20 2018-04-27 中国科学院上海药物研究所 一种盐酸伊立替康组合物及其制备方法
EP3021811A1 (en) * 2013-07-15 2016-05-25 Alchemia Oncology Pty Limited Method of pre-preparing medications for therapeutic uses
US10098813B2 (en) 2014-09-03 2018-10-16 Sun Pharmaceutical Industries Limited Perfusion dosage form
PL3413862T3 (pl) 2016-02-09 2024-03-18 Sun Pharmaceutical Industries Ltd. Układ perfuzyjny

Also Published As

Publication number Publication date
MX2018009670A (es) 2019-09-04
EP4275673A2 (en) 2023-11-15
US20210100947A1 (en) 2021-04-08
CA3014168C (en) 2023-07-04
RU2018131914A (ru) 2020-03-11
CA3014168A1 (en) 2017-08-17
US20230158226A1 (en) 2023-05-25
ZA201805610B (en) 2019-05-29
KR20180120171A (ko) 2018-11-05
US20200360598A1 (en) 2020-11-19
HK1258361A1 (zh) 2019-11-08
BR112018016287A2 (en) 2018-12-18
US12138419B2 (en) 2024-11-12
US11554207B2 (en) 2023-01-17
NZ745728A (en) 2023-08-25
IL261038A (en) 2018-10-31
AU2017218801A1 (en) 2018-09-13
IL261038B2 (en) 2024-06-01
PH12018501693A1 (en) 2019-05-15
MX2022010782A (es) 2022-09-19
ES2968415T3 (es) 2024-05-09
EP3413862B8 (en) 2024-03-13
SA518392177B1 (ar) 2022-08-04
JP2022068326A (ja) 2022-05-09
US20240408295A1 (en) 2024-12-12
EP3413862B1 (en) 2023-10-18
AU2017218801B2 (en) 2021-11-25
JP7059190B2 (ja) 2022-04-25
CN109069342A (zh) 2018-12-21
US11253642B2 (en) 2022-02-22
WO2017138023A1 (en) 2017-08-17
IL261038B1 (en) 2024-02-01
JP2019504699A (ja) 2019-02-21
EP3413862A4 (en) 2019-07-17
RU2728822C2 (ru) 2020-07-31
EP4275673A3 (en) 2023-12-27
KR102524115B1 (ko) 2023-04-20
RU2018131914A3 (pl) 2020-04-30
EP3413862A1 (en) 2018-12-19

Similar Documents

Publication Publication Date Title
GB2567334B (en) Cybersecurity system
PL3697887T3 (pl) Sposoby perfuzyjne
GB201501510D0 (en) System
GB201517101D0 (en) Mixed-reality system
GB201523166D0 (en) Direct integration system
GB201507208D0 (en) Location system
GB2547727B (en) Perfusion phantom
SI3538379T1 (sl) Sistem za delanje zapiskov, ki omogoča brisanje z vlago
PT3073021T (pt) Sistema de conexão
ZA201705600B (en) Track-module bogie-suspension system
ZA201805610B (en) Perfusion system
GB201517276D0 (en) System
IL267759B (en) Spraying device
GB201713486D0 (en) Collision-warning system
PT3379987T (pt) Sistema de fixação de recipiente
HUE066081T2 (hu) Gyors összeszerelõ rendszer
PL3315679T3 (pl) System połączenia
PL3464736T3 (pl) Układ elementu zużywalnego
GB201514541D0 (en) System
GB2557171B (en) Construction system
GB201617213D0 (en) Telescopic-lateral system
TWM533404U (en) Aquaponics system
GB201612966D0 (en) System
GB201601093D0 (en) System
GB201608349D0 (en) Construction system